Boothbay Fund Management’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.12M	Buy	+132,632	New	+$1.26M	0.01%	892
2023 Q3	–	Sell	-17,880	Closed	-$92.3K	–	1973
2023 Q2	$92.3K	Sell	17,880 -17,880	-50%	-$106K	﹤0.01%	1629
2023 Q1	$188K	Hold	35,760	–	–	﹤0.01%	1763
2022 Q4	$100K	Sell	35,760 -11,621	-25%	-$38.5K	﹤0.01%	1784
2022 Q3	$197K	Buy	+47,381	New	+$239K	﹤0.01%	1857
2021 Q4	–	Sell	-41,466	Closed	-$415K	–	2118
2021 Q3	$415K	Sell	41,466 -8,459	-17%	-$95K	0.01%	1174
2021 Q2	$708K	Buy	49,925 +7,748	+18%	+$118K	0.02%	853
2021 Q1	$692K	Sell	42,177 -26,669	-39%	-$514K	0.03%	770
2020 Q4	$1.43M	Sell	68,846 -102,889	-60%	-$1.53M	0.05%	370
2020 Q3	$1.31M	Sell	171,735 -78,977	-32%	-$655K	0.08%	348
2020 Q2	$2.09M	Buy	250,712 +64,763	+35%	+$429K	0.14%	192
2020 Q1	$920K	Buy	185,949 +96,872	+109%	+$478K	0.08%	322
2019 Q4	$352K	Sell	89,077 -1,450	-2%	-$5.04K	0.03%	574
2019 Q3	$275K	Buy	90,527 +73,966	+447%	+$331K	0.03%	597
2019 Q2	$73K	Buy	+16,561	New	+$61.3K	0.01%	675